April 23, 2018 2:51 AM ET

Pharmaceuticals

Company Overview of QuatRx Pharmaceuticals Company

Key Executives for QuatRx Pharmaceuticals Company

NameBoard RelationshipsTitleAge
Robert L. Zerbe M.D.62 RelationshipsCo-Founder, Chief Executive Officer, President and Director66
Stuart Dombey MBNo RelationshipsCo-Founder, Chief Scientific Officer and Chief Regulatory Officer68
Christopher Nicholas No RelationshipsCo-Founder and Chief Operating Officer62
Gary Onn No RelationshipsChief Financial Officer and Principal Accounting Officer59

QuatRx Pharmaceuticals Company Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert L. Zerbe M.D. 62 RelationshipsQuatRx Pharmaceuticals Company66
Richard Palmer Fox 84 RelationshipsUnivar Inc.69
Patrick Heron M.B.A. 47 RelationshipsFrazier Healthcare Partners47
Nicholas J. Simon III 51 RelationshipsClarus Ventures, LLC63
Christopher Moller 15 RelationshipsDevon Park Bioventures64
View All Board Members

QuatRx Pharmaceuticals Company Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Richard Palmer Fox84 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$260.2K
260.2K
321.4K
Bonus$192.6K
192.6K
276.6K
Total Short Term Compensation$3.5M
Not meaningful
Total Value of Options$452.8K
452.8K
10.0M
Compensation as of Fiscal Year 2005
QuatRx Pharmaceuticals Company CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Lannett Names Maureen Cavanaugh as Senior Vice President and Chief Commercial Operations Officer
April 20, 2018 10:53 AM ET
Sihuan Pharmaceutical Holdings Group Ltd. Announces Board Changes
April 20, 2018 9:53 AM ET
Vectura Group plc Announces Resignation of Andrew Derodra as Chief Financial Officer and Executive Director
April 20, 2018 6:00 AM ET
Terra Tech Corp Announces Termination of Kenneth Vande Vrede as Chief Agricultural Officer
April 19, 2018 8:30 PM ET
Dermira, Inc. Appoints Christopher Horan as Chief Technical Operations Officer
April 19, 2018 8:04 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact QuatRx Pharmaceuticals Company, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.